Actionable news
All posts from Actionable news
Actionable news in ESRX: Express Scripts Holding Company,

Horizon Fails Late-Stage Freidreich's Ataxia Trial

Updated from 9:57 a.m. with stock price.

Horizon Pharma (HZNP) shares are poised for volatility after the Irish specialty pharma company revealed the failure of a late-phase trial for a key drug and called it quits on the associated program.

The stock plunged about 15.4% to $16.40 prior to the market's open on Thursday. The stock was down 19.3% to $15.65 as of 10:45 a.m.

The company's phase III Steadfast trial of Actimmune in Friedreich's Ataxia, a genetic condition affecting the nervous system, failed to show...